Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Proteomics01:33

Proteomics

7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

269
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
269
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

202
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
202

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical phenotypes in α<sub>1</sub>-antitrypsin deficiency: a cluster analysis on EARCO data.

ERJ open research·2026
Same author

Biomarkers of Pre-COPD Lung Function Trajectories in Middle Age: A Prospective Study From 1st to 6th Decade.

Respirology (Carlton, Vic.)·2026
Same author

Moving to better COPD care-changes to and challenges for GOLD.

American journal of respiratory and critical care medicine·2026
Same author

The Potential Role of DPP-1 Inhibitors in Chronic Obstructive Pulmonary Disease.

Archivos de bronconeumologia·2026
Same author

Clinical impact of mucus plugs in bronchiectasis.

Scientific reports·2026
Same author

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026

Related Experiment Video

Updated: Jun 29, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.6K

COPD: systemic proteomic profiles in frequent and infrequent exacerbators.

Cesar Jessé Enríquez-Rodríguez1,2,3, Carme Casadevall1,2,3, Rosa Faner2,4

  • 1Servei de Pneumologia, Hospital del Mar - IMIM, MELIS Dept, Universitat Pompeu Fabra and BRN, Barcelona, Spain.

ERJ Open Research
|March 26, 2024
PubMed
Summary

Patients with frequent exacerbations (FE) of chronic obstructive pulmonary disease (COPD) exhibit distinct plasma proteomic profiles. These profiles, involving immune dysregulation, partially overlap with those during acute exacerbations (AE).

More Related Videos

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

557
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

427

Related Experiment Videos

Last Updated: Jun 29, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.6K
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

557
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

427

Area of Science:

  • Proteomics
  • Immunology
  • Respiratory Medicine

Background:

  • Chronic obstructive pulmonary disease (COPD) patients can experience frequent exacerbations (FE), impacting their health outcomes.
  • Systemic proteomic differences between FE and non-frequent exacerbators (NFE) are not well understood.
  • Understanding these proteomic profiles is crucial for targeted therapeutic strategies.

Purpose of the Study:

  • To investigate and contrast the systemic proteomic profiles of COPD patients with FE versus NFE.
  • To establish reference proteomic profiles in healthy controls (HC) and during acute exacerbations (AE) of COPD.

Main Methods:

  • Analysis of plasma samples from stable COPD patients (20 FE, 20 NFE), HC (20), and during AE (10).
  • Utilized label-free liquid chromatography-tandem mass spectrometry and multiplex immunoassays for proteomic analysis.
  • Employed Gene Ontology, pathway enrichment, and network analyses to identify differentially abundant proteins/peptides (DAPs) and associated molecular pathways.

Main Results:

  • Identified 40 DAPs in FE, 10 in NFE, and 63 in AE compared to HC.
  • Revealed dysregulation of innate and antibody-mediated immunity in COPD FE and during AE.
  • Observed alterations in complement and coagulation cascades specifically during AE.

Conclusions:

  • Specific plasma proteome profiles are associated with FE in COPD patients.
  • These FE-related proteomic findings share some similarities with profiles during AE.
  • Unique proteomic alterations are present during actual AE episodes, distinct from stable FE profiles.